Biogen | sciencenewsnet.in

Breaking News

Could the contraceptive pill reduce risk of ovarian cancer?

CBD May Reduce Craving for Alcohol, Study Finds

Lurie Children’s Campaign Urges Parents to Follow Up Right Away if Newborn Screening Results are Abnormal

Combination Approach Helps Prevent Pressure Injuries

February 2025 Issue of Neurosurgical Focus: “Techniques to Reduce and Manage CSF Leaks in Spine and Cranial Surgery”

High-Risk Pregnancy Specialists Analyze AI System to Detect Heart Defects on Fetal Ultrasound Exams

Breast Cancer Didn’t Delay This World Traveler

MSU research: How race, socioeconomic status contribute to math education inequalities

Sexual pleasure in teens: yes, gender matters

How do emotions influence how people deal with natural disasters?

03 Feb, 2025

University of Maryland Medical Center neurologist available for interviews about new Alzheimer’s Disease drug

June 7, 2021 sarah JonasExpert Pitch

News outlets: In your coverage of the historic FDA approval of aducanumab, the first drug approved for disease modification of Alzheimer’s Disease, not just treatment of symptoms, please consider speaking with University of Maryland Medical Center neurologist Dr. Julia Biernot.…

Experts/Patients Available: Historic FDA Alzheimer’s Ruling Expected

June 2, 2021 sarah JonasExpert Pitch

CHICAGO, June 2, 2021 /PRNewswire/ — On, or before, Monday, June 7, the FDA is expected to make a decision on aducanumab (Biogen), a new type of Alzheimer’s treatment. If approved, the decision would be historic. Aducanumab would be the first drug to…